Author's posts
The Health Benefits At The Center Of The United Auto Workers Strike
A key issue in the contract dispute between General Motors and the United Auto Workers is health benefits. Workers have had famously great health plans, paying just 3% of costs.
Status Of Health Benefits Remains Unclear As United Auto Workers’ Strike Continues
While the United Auto Workers strike continues, General Motors and the union are telling different stories about what’s going on with the health benefits of striking workers and their families.
How An ‘International Price Index’ Might Help Reduce Drug Prices
Drugmakers hate the idea. But Nancy Pelosi and Donald Trump both say pegging the prices of U.S. medicine to what people elsewhere pay could save U.S. patients a bundle. Here’s how an “IPI” might work.
For Health Workers Struggling With Addiction, Why Are Treatment Options Limited?
Doctors and nurses are often barred from turning to FDA-approved medications that research shows to be the most effective way to quit. Critics of that policy say stigma is undermining best practice
Treatment Limitations For Physicians With Opioid Addictions
Opioid addiction can happen to anyone, and that includes doctors and nurses. But unlike the general population, they are often barred from medications like methadone, the gold standard of treatment.
Oklahoma Wanted $17 Billion To Fight Its Opioid Crisis: What’s The Real Cost?
The $572 million judgment against Johnson & Johnson will cover one year of addiction treatment and prevention the judge says. But health economists predict it will take decades to abate the problem.
U.S. Overdose Deaths Dipped In 2018, But Some States Saw ‘Devastating’ Increases
Provisional overdose data for 2018 show a note of hope in an overall bleak picture. But in some states, the numbers actually got worse. What explains the disparities?
Car Shopping, Handbags And Wealthy Uncles: The Quest To Explain High Drug Prices
Trump administration officials say drugs’ list prices are like cars’ sticker prices — easily negotiated. But in the life and death world of medicine, health economists say, that analogy falls apart.
As Its Drug Pricing Plans Fall Through, Trump Administration Turns To Congress To Act
It was a tough week for the agency in charge of implementing Trump’s ambitious plans to reduce drug costs. The administration rolled back one plan and had another shot down in court.
Trump Administration Announces Plans To Shake Up The Kidney Care Industry
President Trump has signed an executive order pushing for sweeping changes in the way kidney disease is treated.
